Alkem Laboratories

Alkem Laboratories is an Indian pharmaceutical company that specializes in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces a wide range of branded generics and generic drugs, as well as active pharmaceutical ingredients (APIs), targeting both acute and chronic therapeutic areas. Its product portfolio includes anti-infectives, pain relievers, vitamins and minerals, cardiac and diabetic medications, gynecological products, central nervous system treatments, dermatology solutions, and muscle relaxants. Alkem has established a significant presence in both domestic and international markets, including the United States, Australia, and the United Kingdom. Over the past 12 years, the company has consistently ranked among the top ten pharmaceutical firms in India.

Vikas Gupta

CEO

2 past transactions

Eyestem

Series A in 2022
Eyestem is a cell therapy company founded by a top-class management team consisting of clinical trial, cell therapy and ophthalmology experts. It also boasts a world class advisory board and we have built collaborations with pioneers and leaders in the space. Our long-term vision is to create a global and scalable cell therapy platform to treat incurable diseases. We are developing a cell therapy platform to produce consistent, quality products over the next few years, concentrating on in vitro efficacy and safety.

Zapkey

Seed Round in 2022
Zapkey operates as a proptech and home sales guarantee platform. Zapkey provides its customers with guaranteed home sales within 3 months of the listing date, or they buy the property themselves.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.